The human genome is not a simple instruction manual. It is a chaotic, three-dimensional puzzle that artificial intelligence currently cannot solve. Since the 1950s, scientists have treated DNA as a blueprint or code. That view has proven wrong. We now know that merely reading the sequence of 3 billion chemical blocks does not explain how life works.
The international Human Genome Project mapped the order of these blocks between 1990 and 2003. The result was a surprise. Only 2 percent of the human genome contains actual genes, the sequences that code for proteins. The rest is noncoding DNA. Understanding this vast majority is the real challenge.
The question is no longer what genes do, but how they are regulated. Cells switch genes on and off to create different tissues from the same material. They respond constantly to signals from their environment. These processes are so complex that some biologists doubt human minds can fully grasp them.
Researchers are hoping to outsource the analysis to artificial intelligence. Models like Evo 2, Genos, and Google DeepMind’s AlphaGenome are trained on huge datasets. They predict how DNA differences affect traits and disease risk. These algorithms rely on correlations from known cases. They ignore the complicated regulatory mechanisms. They assume a straightforward input-output relationship.
This approach might yield useful predictions. It will not provide real understanding. The genome does not submit to such simple models. It is not an algorithm.
Karen Adelman, a biologist at Harvard Medical School, noted that the genome is not what we would design if we sat at a drawing board. It is the product of 4 billion years of evolution. The complications are the point.
The traditional view holds that genes code for proteins. There are around 20,000 of these. Making a protein is a two-stage process. First, an enzyme called polymerase reads the DNA to create messenger RNA. This is transcription. Second, a ribosome reads the mRNA to construct the protein. This is translation. The proteins then sustain the organism.
Adelman said the genes are probably not the most interesting part. What matters is regulation. Which proteins a cell needs depends on its type, such as muscle or brain. This depends on noncoding DNA.
Biologists knew about gene regulation since the 1960s. Early studies focused on bacteria. The principles there are straightforward. In complex organisms like humans, regulation involves overlapping systems of control.
Proteins called transcription factors start transcription. They stick to DNA sections and recruit polymerase. In bacteria, these factors act like keys fitting unique locks. In humans, the logic is harder to parse.
Human transcription factors do not show strong preferences for specific binding sites. They often work in pairs or groups. A single factor might activate a gene in one cell type but suppress it in another. This depends on the surrounding factors.
In bacteria, regulation follows an “OR” logic. A signal turns a gene on or off. In the human genome, the logic is more like “AND”. Many signals integrate to reach a decision. Regulation is responsive to context. The knobs are tunable, not just on or off. Adelman called this part of the beauty of our complexity.
Transcription factors bind to pieces of DNA called enhancers. These are gathering points for the factors. They deliver the signal for polymerase to work. Mapping enhancers to their genes is far from straightforward.
The genome has hundreds of thousands, perhaps millions, of enhancers. There are more enhancers than genes. Each gene might be influenced by many enhancers. Each enhancer might influence multiple genes.
Wendy Bickmore, a genome biologist at the University of Edinburgh, said it is embarrassing that 25 years after the Human Genome Project, we do not know where all the enhancers are. We do not know what they do or which genes they control.
Most enhancers do not respond to a single factor. Their activation requires a cocktail. Bickmore said this gives the enhancer exquisite specificity. Only in a particular cell at a particular time do you have the right combination of factors to bind and activate it.
Some enhancers are close to the genes they regulate. Others sit far away, perhaps millions of nucleotides distant. Bickmore called the existence of these distal enhancers bonkers. She asked how information travels from over there to over here to activate the gene. That is a largely unanswered question.
One answer is a loop. Distal enhancers are brought to the gene on loops of chromatin. Chromatin is DNA and its packaging proteins. Cohesin is a protein motor that runs up and down the strand. It extrudes the DNA as needed to form a loop.
Once cohesin forms a loop, the components do not stick together. They form a loose but dense blob. They interact weakly, fleetingly, and indiscriminately. This is a sort of committee called a condensate.
These transcription hubs are extremely fluid. They differ from one cell to another. Bickmore said there will be loop extrusion going on over here in one cell. In the next cell, it might be over there. The whole thing turns over incredibly fast. Even if cells are notionally identical, the gene-regulatory machinery is never quite the same in any two of them.
Chromatin loops explain why a gene’s transcription depends on the shape of the chromatin around it.
The textbook image of a chromosome is a compact, X-shaped cluster. But when a cell is not actively dividing, its chromatin unwinds into a tangled mess. There is order to the chaos. Some parts are densely packed into heterochromatin. The DNA there is inaccessible. The genes are typically silenced. Other parts are loose, open, and accessible. This is euchromatin.
Special enzymes package and repack chromatin to control transcription. What matters is not just the encoded information but how it exists physically and dynamically in space. Bickmore said we have stopped thinking about the genome as a linear piece of DNA code. Thinking about this incredibly dynamic three-dimensional folding as inherent to regulation is an exciting change.
One aspect of this 3D organization is the clustering of segments into compartments called topologically associating domains. Within a TAD, genes seem to be coregulated. They switch on or off in groups. These groups keep suites of genes active or silent together to form different cell types. Cohesin is involved in shuffling chromatin to construct TADs. This is a dynamic process of constant rearrangement.
Chromatin shape is also influenced by chemical modifications called epigenetic marks. These are small molecules attached to histones or stuck directly to DNA. Some modifications alter the electrical charges on histones. This changes how proteins attract or repel one another. It rejigs the packing. Epigenetic modifications are like annotations of the DNA script that change its meaning in a given context. When cells divide, the annotations are copied too.
How and when the marks get added and changed, and what each type means for gene activity, are complex questions with no simple answers. Some researchers talk of an epigenetic code. It is far from clear if anything so systematic really exists.
All of these processes determine whether a gene is active or silent. They show that the genome is not a static script. It is a dynamic, three-dimensional structure that resists simple explanation.
